Pathfinders in Biopharma podcast

How Blackstone Life Sciences is bridging the innovation gap

0:00
20:59
Rewind 15 seconds
Fast Forward 15 seconds

Paris Panayiotopoulos, Senior Managing Director at Blackstone Life Sciences, shares how the firm’s broad life sciences strategy has been advancing innovation across the life sciences ecosystem in three key ways: late-stage product financing (Collaboration) and new company creation (Ownership), and non-dilutive financing (Credit and Royalties). He explains how Blackstone is bridging the innovation funding gap through high-conviction partnerships with larger BioPharma and MedTech companies, and targeted investment in late-stage trials.

More episodes from "Pathfinders in Biopharma"